Indeed, pathogenic CHD7 mutations usually disturb chromatin-modifying activity, implying a possible epigenetic origin for CHARGE syndrome, which could be explained by the role that CHD7 plays in significant developmental pathways such as BMP [94], altering cell migration, and the development of cell lineages like the cardiac mesoderm [97]. Here, CHD7 is linked to CHARGE syndrome.